1. Home
  2. TLS vs VYGR Comparison

TLS vs VYGR Comparison

Compare TLS & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$5.18

Market Cap

463.8M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
VYGR
Founded
1969
2013
Country
United States
United States
Employees
N/A
172
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.8M
226.8M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
TLS
VYGR
Price
$5.18
$4.08
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$7.75
$17.00
AVG Volume (30 Days)
1.0M
433.3K
Earning Date
11-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$144,400,000.00
$31,316,000.00
Revenue This Year
$52.27
N/A
Revenue Next Year
$20.44
$71.78
P/E Ratio
N/A
N/A
Revenue Growth
17.44
N/A
52 Week Low
$1.83
$2.65
52 Week High
$8.36
$6.27

Technical Indicators

Market Signals
Indicator
TLS
VYGR
Relative Strength Index (RSI) 39.52 45.47
Support Level $4.97 $3.93
Resistance Level $5.85 $4.26
Average True Range (ATR) 0.33 0.21
MACD -0.01 -0.02
Stochastic Oscillator 15.40 21.53

Price Performance

Historical Comparison
TLS
VYGR

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: